Pharming Group to report third quarter 2024 financial results on October 24
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) has announced that it will release its preliminary (unaudited) third quarter 2024 financial results on Thursday, October 24, 2024. The results will cover the period ended September 30. The company will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on the same day.
To participate in the conference call, interested parties must register in advance using the provided link. Upon registration, dial-in information and a unique PIN will be provided for call access. The company will only take questions from dial-in attendees. Additionally, a live webcast of the presentation will be available, with a separate registration link provided for those who wish to watch online.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) ha annunciato che pubblicherà i suoi risultati finanziari preliminari (non verificati) del terzo trimestre 2024 il giovedì 24 ottobre 2024. I risultati copriranno il periodo terminato il 30 settembre. L'azienda ospiterà una presentazione per analisti e investitori alle 13:30 CEST/07:30 am EDT nello stesso giorno.
Per partecipare alla conferenza telefonica, le parti interessate devono registrarsi in anticipo utilizzando il link fornito. Dopo la registrazione, verranno forniti le informazioni per la telefonata e un PIN unico per accedere alla chiamata. L'azienda accetterà domande solo dai partecipanti che si sono collegati. Inoltre, sarà disponibile una trasmissione in diretta della presentazione, con un link di registrazione separato per coloro che desiderano guardare online.
Pharming Group N.V. (Euronext Ámsterdam: PHARM/Nasdaq: PHAR) ha anunciado que publicará sus resultados financieros preliminares (no auditados) del tercer trimestre de 2024 el jueves 24 de octubre de 2024. Los resultados cubrirán el período terminado el 30 de septiembre. La empresa llevará a cabo una presentación para analistas e inversores a las 13:30 CEST/07:30 am EDT el mismo día.
Para participar en la llamada de conferencia, las partes interesadas deben registrarse con anticipación utilizando el enlace proporcionado. Tras la inscripción, se proporcionará información para la llamada y un PIN único para acceder. La empresa solo aceptará preguntas de los asistentes que se hayan conectado. Además, estará disponible una transmisión en vivo de la presentación, con un enlace de registro separado para aquellos que deseen ver en línea.
Pharming Group N.V. (유로넥스트 암스테르담: PHARM/나스닥: PHAR)는 2024년 3분기 재무 결과(검증되지 않음)를 2024년 10월 24일 목요일에 발표할 것이라고 발표했습니다. 이 결과는 9월 30일로 종료된 기간을 포함합니다. 회사는 같은 날 CEST 13:30/EDT 07:30에 애널리스트와 투자자를 위한 프레젠테이션을 개최할 것입니다.
컨퍼런스 콜에 참여하려면 관심 있는 당사자가 제공된 링크를 사용하여 미리 등록해야 합니다. 등록 후, 전화 접속 정보와 고유한 PIN이 제공됩니다. 회사는 전화 연결 참석자들로부터만 질문을 받을 것입니다. 또한, 프레젠테이션의 실시간 웹캐스트가 제공되며, 온라인 관람을 원하는 분들을 위해 별도의 등록 링크가 제공됩니다.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) a annoncé qu'elle publiera ses résultats financiers préliminaires (non vérifiés) pour le troisième trimestre 2024 le jeudi 24 octobre 2024. Les résultats couvriront la période se terminant le 30 septembre. L'entreprise tiendra une présentation pour les analystes et les investisseurs à 13:30 CEST/07:30 am EDT le même jour.
Pour participer à la conférence téléphonique, les parties intéressées doivent s'inscrire à l'avance en utilisant le lien fourni. Après l'inscription, des informations de connexion et un code PIN unique seront fournis pour accéder à l'appel. L'entreprise n'acceptera des questions que des participants au téléphone. De plus, une diffusion en direct de la présentation sera disponible, avec un lien d'inscription séparé pour ceux qui souhaitent regarder en ligne.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) hat angekündigt, dass sie ihre vorläufigen (nicht geprüften) Finanzergebnisse für das dritte Quartal 2024 am Donnerstag, den 24. Oktober 2024 veröffentlichen wird. Die Ergebnisse beziehen sich auf den Zeitraum bis zum 30. September. Das Unternehmen wird am selben Tag um 13:30 CEST/07:30 am EDT eine Präsentation für Analysten und Investoren veranstalten.
Um an der Telefonkonferenz teilzunehmen, müssen sich interessierte Parteien im Voraus über den bereitgestellten Link registrieren. Nach der Registrierung werden Informationen zur Einwahl und eine eindeutige PIN für den Zugang zur Konferenz bereitgestellt. Das Unternehmen wird Fragen nur von eingewählten Teilnehmern entgegennehmen. Darüber hinaus wird eine Live-Übertragung der Präsentation verfügbar sein, mit einem separaten Registrierungslink für diejenigen, die online zuschauen möchten.
- None.
- None.
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2024 financial results, for the period ended September 30, on Thursday, October 24, 2024.
Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on October 24, 2024.
To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.
Conference call registration:
Please note, the Company will only take questions from dial-in attendees.
https://register.vevent.com/register/BId118ac68d9124f67b1a83e3769559100
To watch the live webcast, please register in advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/yotjk8ib
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
When will Pharming Group report its Q3 2024 financial results?
What period will Pharming's Q3 2024 financial results cover?
What time is Pharming's Q3 2024 earnings presentation scheduled for?
How can investors participate in Pharming's Q3 2024 earnings call?
Will there be a webcast available for Pharming's Q3 2024 earnings presentation?
